Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. - Wikidata - wikimedia - TriplyDB

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34888769

about

Beclometasone for chronic obstructive pulmonary disease Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Beclometasone for COPD Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease Sirtuin 1 and aging theory for chronic obstructive pulmonary disease Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function Effects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trial The best of respiratory infections from the 2015 European Respiratory Society International Congress Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit Copd.Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD Pharmacotherapy and the risk for community-acquired pneumonia."Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study".Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions HIV-associated obstructive lung diseases: insights and implications for the clinician.Influencing the decline of lung function in COPD: use of pharmacotherapy.Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.Scientific respiratory symposium, paris june 2010 Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study.The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology.

P2860

Q24197535-93C39EDF-907E-4E96-90B7-E2565B293E4F Q24197989-AFD05B4B-4864-4B31-934F-E95E399A9A1E Q24199130-723EE3B1-1436-4B97-AA66-1678330BB156 Q24200572-A801E6B3-1B5D-482B-B9D4-EC2E81497E35 Q26741051-6CB2828E-8D43-4A50-ABCC-90044F27E902 Q26799889-E3CC47DF-7103-49C7-91E9-E7D8BFE57C72 Q27025647-501428F1-3DE4-4FBB-8A0C-0EDC0858EF18 Q28397453-99A0933D-2D5A-4128-9B12-ACB1A9297684 Q28541874-495C38B1-1478-4843-967E-FF46C4F1AE25 Q28598393-DC7184A3-067D-41AF-9B18-D0C2FEDF446E Q28602277-2E668AC1-461E-4DEE-88E3-CBF296388BAD Q28761895-C18922B1-A92E-4D6C-85E0-1DF92B413F5D Q30982948-3A2ED011-CBFE-4ED6-BD3E-E288CA94BECF Q31016356-D1462D91-DF03-460C-BBCB-426E7509DEB4 Q31138448-2CF76D2E-91B5-4ED2-8A7B-7D3664ECFBF4 Q33558856-5053E629-8249-4A99-8F70-43B45998A91D Q33626068-99B7C73B-E5CB-4072-8949-545D7B6B03E1 Q33643053-B638B3C4-C407-4228-9FC6-EA1CC72E1A1A Q33689926-6D3ABAA3-8C49-4BC5-88C9-265ECC0C93A8 Q33705358-DC8C9604-EC1F-4D19-A5F5-36D8D078361E Q33709357-AF42DAEB-B5C0-4561-A29A-9BDBE420E9C3 Q33782854-C4DAC068-211A-436A-ABF8-88A0693D26FB Q33790645-EA5302C3-2B9A-48D7-9B04-A70AF1D143C8 Q33803143-37962A38-DB56-494C-B95F-C2DAF457F128 Q33931328-46E2F853-FCF8-4A41-B865-B6FDF62D16F5 Q33950594-070278AC-8640-46A5-A417-9D8717B33000 Q33966001-39EC5E9D-8CF8-436D-B663-BC6C6B9D0088 Q34015461-D950158C-F71D-4F26-9906-B23C20A463D0 Q34036358-0767FC53-17E0-4C56-9EF4-CF879BF080CB Q34065276-34B17D21-D29B-43E0-B094-C04B17C0A615 Q34065958-AF9AE20E-B9F9-4BE0-967E-D537759D768C Q34350843-BC64BE96-7888-4A4D-AC2F-37720E062B70 Q34693477-1275B928-99C5-4C76-8BC8-18E334E1CAF6 Q35028812-379C6CC9-4520-42C1-870D-5A7A301C5A51 Q35117833-8F64F6D7-9CAC-4CB6-A99F-82DD4A05DDBA Q35119108-87C14F13-14C7-47A5-9F41-BED941E3264A Q35128794-07BD2BDC-07AE-472E-A002-8C4EC9E905A7 Q35173527-6E18F09A-6656-4F58-BEE0-1DC3A2C58419 Q35219711-007C3363-AD7B-4B58-B126-71E2C06CEDF6 Q35257612-3A6CDE6C-BD9C-490F-BF6B-C348C8D99269

P2860

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34888769

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@ast

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@en

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@nl

type

label

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@ast

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@en

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@nl

prefLabel

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@ast

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@en

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@nl

P1433

Q34888769-54940158-E63B-424C-AD27-A14795DDFB80

P1476

Q34888769-CCA95B7F-5EB8-4AEF-B187-56ED13E235B6

P2093

Q34888769-0635B4F2-030B-4975-B23C-50527F7E0F1C

Q34888769-D84AE1C1-554F-4C3E-8103-3CB7F92CBAEC

Q34888769-F3AF731F-A234-4A7F-AE76-F7AAB3CF81BB

P2860

Q34888769-04A40EBE-1FEC-459D-A711-2119423FEFED

Q34888769-0DDB2429-70A9-4B3C-B6FB-D33E3A925E20

Q34888769-1822A8E5-5C21-4104-8725-515B8802B60B

Q34888769-1DC41383-40A0-4466-8702-8C2EB2A99F04

Q34888769-207EE4A1-FAC2-4AD7-936E-AAE448C8AF35

Q34888769-25E33F8D-5A64-497F-AC04-DC11D55F25A6

Q34888769-2D175734-0647-4B0C-8828-9894095E99C1

Q34888769-482EF685-8982-4418-963E-2D20BBA1D05A

Q34888769-4D36E76F-3EB3-4200-BE11-DAFB45A38EE4

Q34888769-54C74E49-772A-4B08-AEAD-29B36C709F44

P304

Q34888769-CA3A7EDB-1DBA-45B8-94E8-FEBFC9B7690E

P31

Q34888769-09b11b01-8dd8-4f86-a1a9-dc544a66a695

Q34888769-192167A6-0F80-4C9E-904C-F4530E21492C

P356

Q34888769-523AC6BB-A83F-41A9-9566-9458E2115AEB

P407

Q34888769-536EA593-B788-4FEA-A4C2-AB6219A17D1A

P433

Q34888769-62A23D09-3173-4EFB-A609-0E659CBDEE48

P478

Q34888769-441F3ABD-D7EE-41FA-9808-43A545481D40

P50

Q34888769-38F955FE-F145-4B3A-A3E6-6478E206D58F

Q34888769-E7C8D651-7D03-4837-B54D-C7695BCBAC2A

P577

Q34888769-5BAEB6B8-A5FF-4101-BC60-7FD155CB5087

P5875

Q34888769-948262FE-DB13-4859-ADC9-3AE3B8B3290D

P698

Q34888769-F0E93A58-F2F3-4C93-BD21-3F4897CC067E

P921

Q34888769-005485D5-A2D0-43E1-A339-D8899228E4D4

Q34888769-60070D8B-B2AC-4D00-BDFE-D2BDA756305D

Q34888769-CF90BE78-2CD5-4F2B-8912-A08DE4C6F93E

P932

Q34888769-E0B06073-AB02-4999-BD13-BE73DE803AD2

P356

P1433

Journal of the American Medical Association

P1476

Inhaled corticosteroids in pat ...... atic review and meta-analysis.

@en

P2093

David J Murphy

http://www.w3.org/2001/XMLSchema#string

M Bradley Drummond

http://www.w3.org/2001/XMLSchema#string

Marshall W Pitz

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes

Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

The Measurement of Observer Agreement for Categorical Data

Operating characteristics of a rank correlation test for publication bias

Measuring inconsistency in meta-analyses

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

P304

2407-2416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2008.717

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

300

http://www.w3.org/2001/XMLSchema#string

P50

Elliott C. Dasenbrook

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23497443

http://www.w3.org/2001/XMLSchema#string

P698

19033591

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

4804462

http://www.w3.org/2001/XMLSchema#string